Cited by 830Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, Suzanne, Stennis Watson, G·2004·The Lancet Neurology

DOI 10.1016/s1474-4422(04)00681-7

Open this paper in CoChat — free account

Abstract

Insulin has functions in the brain and dysregulation of these functions may contribute to the expression of late-life neurodegenerative disease. We provide a brief summary of research on the influence of insulin on normal brain function. We then review evidence that perturbation of this role may contribute to the symptoms and pathogenesis of various neurodegenerative disorders, such as Alzheimer's disease, vascular dementia, Parkinson's disease, and Huntington's disease. We conclude by considering whether insulin dysregulation contributes to neurodegenerative disorders through disease-specific or general mechanisms.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(04)00681-7

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
The Endocrine Regulation of Aging by Insulin-like Signals
Tatar, M., Bartke, A., & Antebi, A. (2003) · Science · doi:10.1126/science.1081447 · Cited by 1,327
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Insulin receptors are widely distributed in the central nervous system of the rat
Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116
Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes
Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064

Show all 145 references

Research works printed but not linked: 1

Schobotz, 1976, Fatty acid patterns and glucose tolerance in Huntington's chorea, Res Exp Med (Berl), 167, 203

Sorted by citations

Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Self-citation
Cognition and diabetes: a lifespan perspective
Biessels, G. J., Deary, I. J., & Ryan, C. M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70021-8 · Cited by 662
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 619
Self-citation
Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone
Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 614
Self-citation
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547
Self-citation
Brain abnormalities in human obesity: A voxel-based morphometric study
Pannacciulli, N., Del Parigi, A., Chen, K., Le, D. S. N. T., Reiman, E. M., & Tataranni, P. A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.047 · Cited by 523
Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487
Self-citation
Type 2 Diabetes and the Risk of Parkinson's Disease
Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
Claxton, A., Baker, L. D., Hanson, A., Trittschuh, E. H., Cholerton, B., Morgan, A., Callaghan, M., Arbuckle, M., Behl, C., & Craft, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141791 · Cited by 467
Self-citation
Insulin signaling in the central nervous system: Learning to survive
van der Heide, L. P., Ramakers, G. M. J., & Smidt, M. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.06.003 · Cited by 444
Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis
O’Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., Eimer, W. A., Hitt, B. D., Bembinster, L. A., Lammich, S., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.047 · Cited by 429
Biological mechanisms underlying the role of physical fitness in health and resilience
Silverman, M. N., & Deuster, P. A. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0040 · Cited by 416
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Risk factors for progression of brain atrophy in aging
Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S. M., & Schmidt, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161871.83614.bb · Cited by 397
Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance
McNay, E. C., Ong, C. T., McCrimmon, R. J., Cresswell, J. A., Bogan, J. S., & Sherwin, R. S. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.02.002 · Cited by 425
Antidiabetic drug metformin (Glucophage R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390
Overweight Is Associated With Decreased Cognitive Functioning Among School‐age Children and Adolescents
Li, Y., Dai, Q., Jackson, J. C., & Zhang, J. (2008) · Obesity · doi:10.1038/oby.2008.296 · Cited by 387
(Pre)diabetes, brain aging, and cognition
Roriz‐Filho, J. S., Roriz, T. M. D. S., Rosset, I., Camozzato, A. L., dos Santos, A. C., Chaves, M. L. F., Moriguti, J. C., & Roriz‐Cruz, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.003 · Cited by 397
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387
Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation
Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.021 · Cited by 347
Self-citation
Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease
Kapogiannis, D., Boxer, A. L., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U. B., Frassetto, L. A., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345
A life-course approach to the aetiology of late-onset dementias
Whalley, L. J., Dick, F. D., & McNeill, G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70286-6 · Cited by 358
Amylin deposition in the brain: A second amyloid in Alzheimer disease?
Jackson, K., Barisone, G. A., Díaz, E., Jin, L., DeCarli, C. S., & Despa, F. (2013) · Annals of Neurology · doi:10.1002/ana.23956 · Cited by 349
Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease
Cao, D., Lu, H., Lewis, T. L., & Li, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703561200 · Cited by 336
Insulin Signaling in the Central Nervous System
Porte, D., Baskin, D. G., & Schwartz, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1264 · Cited by 339
Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
Felice, F. G. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 336
High-fat diets, insulin resistance and declining cognitive function
Greenwood, C. E., & Winocur, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.017 · Cited by 339
Insulin in Central Nervous System: More than Just a Peripheral Hormone
Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 337
Type 2 diabetes mellitus and Alzheimer’s disease
Barbagallo, M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.889 · Cited by 313
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 323
Impairment of the glymphatic system after diabetes
Jiang, Q., Zhang, L., Ding, G., Davoodi-Bojd, E., Li, Q., Li, L., Sadry, N., Nedergaard, M., Chopp, M., & Zhang, Z. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654702 · Cited by 308
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 316
Metabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders
Cai, H., Cong, W., Ji, S., Rothman, S. M., Maudsley, S. R., & Martin, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015064 · Cited by 302
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 326
Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart
Benedict, C., Hallschmid, M., Schmitz, K., Schultes, B., Ratter, F., Fehm, H. L., Born, J., & Kern, W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301193 · Cited by 302
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 300
Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., Painter, M. M., Sullivan, P. M., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.003 · Cited by 289
Association of metabolic syndrome with Alzheimer disease
Vanhanen, M., Koivisto, K. J., Moilanen, L., Helkala, E.-L., Hänninen, T., Soininen, H. S., Kervinen, K., Kesäniemi, Y. A., Laakso, M., & Kuusisto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000234037.91185.99 · Cited by 295
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Bedse, G., Domenico, F. D., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 313
2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia
Emmerzaal, T. L., Kiliaan, A. J., & Gustafson, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141086 · Cited by 303
Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284
Parkinson's disease, insulin resistance and novel agents of neuroprotection
Avilés-Olmos, I., Limousin, P. D., Lees, A. J., & Foltynie, T. (2012) · Brain · doi:10.1093/brain/aws009 · Cited by 291
Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277
Memory impairment in obese Zucker rats: An investigation of cognitive function in an animal model of insulin resistance and obesity.
Winocur, G., Greenwood, C. E., Piroli, G. G., Grillo, C. A., Reznikov, L. R., Reagan, L. P., & McEwen, B. S. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1389 · Cited by 292
Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
Neth, B. J., & Craft, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00345 · Cited by 284
Self-citation
Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study
Huang, C., Chung, C., Leu, H., Lin, L., Chiu, C.-C., Hsu, C., Chiang, C.-H., Huang, P., Chen, T., Lin, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087095 · Cited by 272
Insulin resistance predicts brain amyloid deposition in late middle‐aged adults
Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 267
Self-citation
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Cognitive dysfunction in patients with type 2 diabetes
Reijmer, Y. D., van den Berg, E., Ruis, C., Kappelle, L. J., & Biessels, G. J. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1112 · Cited by 258
Amyloid-β as a Modulator of Synaptic Plasticity
Parihar, M. S., & Brewer, G. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101020 · Cited by 264
Diabetes and Risk of Parkinson’s Disease
Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., & Pezzoli, G. (2011) · Diabetes Care · doi:10.2337/dc11-1584 · Cited by 247
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner, Z. (2009) · PubMed · Cited by 246
Diabetes mellitus and Parkinson disease
Pagano, G., Polychronis, S., Wilson, H., Giordano, B., Ferrara, N., Niccolini, F., & Politis, M. (2018) · Neurology · doi:10.1212/wnl.0000000000005475 · Cited by 243
High-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity
Liu, Z., Patil, I., Jiang, T., Sancheti, H., Walsh, J. P., Stiles, B. L., Yin, F., & Cadenas, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128274 · Cited by 250
The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
Cheong, J. L. Y., Pablo‐Fernández, E. D., Foltynie, T., & Noyce, A. J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191900 · Cited by 241
Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes
McNay, E. C., & Recknagel, A. K. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.005 · Cited by 233
Insulin, cognition, and dementia
Cholerton, B., Baker, L. D., & Craft, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.008 · Cited by 243
Self-citation
Incident dementia in women is preceded by weight loss by at least a decade
Knopman, D. S., Edland, S. D., Cha, R. H., Petersen, R. C., & Rocca, W. A. (2007) · Neurology · doi:10.1212/01.wnl.0000267661.65586.33 · Cited by 226
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
Willette, A. A., Xu, G., Johnson, S. C., Birdsill, A. C., Jonaitis, E. M., Sager, M. A., Hermann, B. P., Rue, A. L., Asthana, S., & Bendlin, B. B. (2012) · Diabetes Care · doi:10.2337/dc12-0922 · Cited by 233
The genetic landscape of Parkinson's disease
Lunati, A., Lesage, S., & Brice, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.004 · Cited by 231
Diabetes Mellitus and Dementia
Ninomiya, T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0487-z · Cited by 218
Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects
Jl, T., Piriz, J., Llorens-Martı́n, M., Fernandez, A. M., Bolós, M., LeRoith, D., Núñez, Á., & Torres‐Alemán, I. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002076 · Cited by 210
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies
Yarchoan, M. M., Toledo, J. B., Lee, E. B., Arvanitakis, Z., Kazi, H., Han, L.-Y., Louneva, N., Lee, V. M. ‐., Kim, S. F., Trojanowski, J. Q., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1328-5 · Cited by 215
A biochemical and functional characterization of diet‐induced brain insulin resistance
Mielke, J. G., Taghibiglou, C., Liu, L., Zhang, Y., Jia, Z., Adeli, K., & Wang, Y. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03155.x · Cited by 210
The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid
Lee, H.-K., Kumar, P., Fu, Q., Rosen, K. M., & Querfurth, H. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0777 · Cited by 185
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., & Kennedy, S. H. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.157 · Cited by 203
Type 2 Diabetes and Cognitive Impairment: Linking Mechanisms
Luchsinger, J. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111433 · Cited by 205
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes
Manschot, S., Biessels, G. J., de Valk, H. W., Algra, A., Rutten, G. E. H. M., van der Grond, J., Kappelle, L. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0792-z · Cited by 202
Type 2 diabetes and risk of cognitive impairment and dementia
Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 201
Risk of Parkinson Disease in Diabetes Mellitus
Yue, X., Li, H., Yan, H., Zhang, P., Li, C., & Li, T. (2016) · Medicine · doi:10.1097/md.0000000000003549 · Cited by 189
DPP 4‐inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high‐fat diet consumption
Pipatpiboon, N., Pintana, H., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12088 · Cited by 183
Risk of Parkinson Disease Onset in Patients With Diabetes
Sun, Y., Chang, Y., Chen, H.-F., Su, Y., Su, H.-F., & Li, C. (2012) · Diabetes Care · doi:10.2337/dc11-1511 · Cited by 185
Diabetes and Insulin in Regulation of Brain Cholesterol Metabolism
Suzuki, R., Lee, K., Jing, E., Biddinger, S. B., McDonald, J. G., Montine, T. J., Craft, S., & Kahn, C. R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.006 · Cited by 169
Self-citation
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder
McCutchan, J. A., Marquie‐Beck, J., Fitzsimons, C., Letendre, S. L., Ellis, R. J., Heaton, R. K., Wolfson, T. J., Rosario, D., Alexander, T. J., Marra, C. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182478d64 · Cited by 179
Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease
Rasgon, N., Kenna, H. A., Wroolie, T., Kelley, R. G., Silverman, D. H. S., Brooks, J. O., Williams, K. E., Powers, B. N., Hallmayer, J. F., & Reiss, A. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.005 · Cited by 180
RETRACTED: Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy
Francis, G. J., Martinez, J. A., Liu, W. Q., Xu, K., Ayer, A. B., Fine, J. M., Tuor, U. I., Glazner, G. W., Hanson, L. R., Frey, W. H., et al. (2008) · Brain · doi:10.1093/brain/awn288 · Cited by 175
Retracted
Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline
Gaspar, J. M., Baptista, F. I., Macedo, M. P., & Ambrósio, A. F. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00240 · Cited by 183
Intranasal Insulin for Alzheimer’s Disease
Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 188
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 177
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
Noyce, A. J., Kia, D. A., Hemani, G., Nicolas, A., Price, T. R., Pablo‐Fernández, E. D., Haycock, P., Lewis, P. A., Foltynie, T., Smith, G. D., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002314 · Cited by 174
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
Geldmacher, D. S., Fritsch, T., McClendon, M. J., & Landreth, G. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.229 · Cited by 221
Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications
Craft, S. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213866.86934.7e · Cited by 167
Self-citation
Clinical features of Parkinson disease when onset of diabetes came first
Cereda, E., Barichella, M., Cassani, E., Caccialanza, R., & Pezzoli, G. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553cc9 · Cited by 166
Obesity, diabetes, and risk of Parkinson's disease
Palacios, N., Gao, X., McCullough, M. L., Jacobs, E. J., Patel, A. V., Mayo, T. L., Schwarzschild, M. A., & Ascherio, A. (2011) · Movement Disorders · doi:10.1002/mds.23855 · Cited by 170
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S. L., Alsuwaidan, M. T., Yim, C. Y., & McIntyre, R. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 167
Does the brain shrink as the waist expands?
Willette, A. A., & Kapogiannis, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.007 · Cited by 162
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms
Panza, F., Frisardi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Santamato, A., D’Onofrio, G., Seripa, D., Sancarlo, D., Pilotto, A., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091669 · Cited by 166
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 171
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
Beeri, M. S., Schmeidler, J., Silverman, J. M., Gandy, S., Wysocki, M., Hannigan, C. M., Purohit, D. P., Lesser, G., Grossman, H. T., & Haroutunian, V. (2008) · Neurology · doi:10.1212/01.wnl.0000324925.95210.6d · Cited by 157
Insulin resistance and outcome in bipolar disorder
Calkin, C., Růžičková, M., Uher, R., Hájek, T., Slaney, C., Garnham, J. S., O’Donovan, M. C., & Alda, M. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152850 · Cited by 165
Metabolome in schizophrenia and other psychotic disorders: a general population-based study
Orešič, M., Tang, J. P., Seppänen‐Laakso, T., Mattila, I. M., Saarni, S. E., Saarni, S. I., Lönnqvist, J. K., Sysi‐Aho, M., Hyötyläinen, T., Perälä, J., et al. (2011) · Genome Medicine · doi:10.1186/gm233 · Cited by 160
Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link
Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2240-3 · Cited by 163
Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
Pasinetti, G. M., & Eberstein, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05454.x · Cited by 160
Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women
Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Helkala, E., Haapala, I., Nissinen, A. M., & Rauramaa, R. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096636 · Cited by 156

Authors: Craft, S., & Stennis Watson, G.
Affiliations: University of Washington (US)
Corresponding author: Craft, Suzanne
ORCID: Craft, Suzanne
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2004-03
Volume: 3
Issue: 3
Pages: 169-178
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(04)00681-7
OpenAlex: W2145451941
Cited by: 830
References: 145
Citations by year: 2026: 17 · 2025: 26 · 2024: 29 · 2023: 37 · 2022: 36 · 2021: 27 · 2020: 49 · 2019: 42 · 2018: 36 · 2017: 36 · 2016: 43 · 2015: 37 · 2014: 66 · 2013: 44 · 2012: 48
FWCI: 3.57
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (R01-AG-10880, R01AG010880)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061606, DK61606)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: insulin, neurodegenerative diseases, brain insulin signaling, Alzheimer's disease, vascular dementia, Parkinson's disease, Huntington's disease, insulin dysregulation, late-life cognitive decline
MeSH terms: Animals, Brain, Cognition Disorders, Diabetes Mellitus, Energy Metabolism, Humans, Insulin, Receptor, Insulin, Signal Transduction, Neurodegenerative Diseases, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin and neurodegenerative disease: shared and specific mechanisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks